Mustang Bio gets Nasdaq extension until April 12, 2027, to meet minimum bid price requirement

• Nasdaq granted Mustang Bio an additional 180 days on October 13, 2026, extending its minimum bid-price compliance deadline to April 12, 2027.
• The extension follows failure to regain compliance by October 12, 2026, following 30 consecutive business days with closing bids below $1.00.
• Compliance requires a closing bid of at least $1.00 per share for at least 10 consecutive business days, generally no more than 20.
• A reverse stock split remains an option to restore compliance with Nasdaq's minimum bid-price requirement.
• Failure to comply by the extended deadline would trigger a delisting notice; an appeal would not pause any trading suspension.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mustang Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-116233), on October 15, 2026, and is solely responsible for the information contained therein.